業績

2013年度 :: 著書・雑誌 :: 英文 :: 原著 :: 業績

Factors associated with risk for colorectal cancer recurrence after endoscopic resection of T1 tumors.

Yoshii S, Nojima M, Nosho K, Omori S, Kusumi T, Okuda H, Tsukagoshi H, Fujita M, Yamamoto H, Hosokawa M.

Clin Gastroenterol Hepatol. 2014; 12(2): 292-302

Japanese multicenter experience of endoscopic necrosectomy for infected walled-off pancreatic necrosis: The JENIPaN study.

Yasuda I, Nakashima M, Iwai T, Isayama H, Itoi T, Hisai H, Inoue H, Kato H, Kanno A, Kubota K, Irisawa A, Igarashi H, Okabe Y, Kitano M, Kawakami H, Hayashi T, Mukai T, Sata N, Kida M, Shimosegawa T.

Endoscopy. 2013; 45(8): 627-634

Preliminary report on a new, fully covered, metal stent designed for the treatment of pancreatic fluid collections.

Yamamoto N, Isayama H, Kawakami H, Sasahira N, Hamada T, Ito Y, Takahara N, Uchino R, Miyabayashi K, Mizuno S, Kogure H, Sasaki T, Nakai Y, Kuwatani M, Hirano K, Tada M, Koike K.

Gasrointest Endosc. 2013; 77(5): 809-814

Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells.

Yamahara K, Harada K, Ohshima M, Ishikane S, Ohnishi S, Tsuda H, Otani K, Taguchi A, Soma T, Ogawa H, Katsuragi S, Yoshimatsu J, Harada-Shiba M, Kangawa K, Ikeda T.

PLoS One. 2014; 9(2): e88319

Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.

Yamaguchi K, Sawaki A, Doi T, Satoh T, Yamada Y, Omuro Y, Nishina T, Boku N, Chin K, Hamamoto Y, Takiuchi H, Komatsu Y, Saji S, Koizumi W, Miyata Y, Sato A, Baba E, Tamura T, Abe T, Ohtsu A.

Gastric Cancer. 2013; 16(2): 175-182

Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, noninferiority, randomised phase 3 trial.

Yamada Y, Takahari D, Matsumoto H, Baba H, Nakamura M, Yoshida K, Yoshida M, Iwamoto S, Shimada K, Komatsu Y, Sasaki Y, Satoh T, Takahashi K, Mishima H, Muro K, Watanabe M, Sakata Y, Morita S, Shimada Y, Sugihara K.

Lancet Oncol. 2013; 14(13): 1278-1286

Rikkunshito, a Japanese Kampo medicine, ameliorates decreased feeding behavior via ghrelin and serotonin 2B receptor signaling in a novelty stress murine model.

Yamada C, Saegusa Y, Nakagawa K, Ohnishi S, Muto S, Nahata M, Sadakane C, Hattori T, Sakamoto N, Takeda H.

BioMed Res Int. 2013: 792940

Randomised phase II study comparing dose-escalated weekly paclitaxel vs standard-dose weekly paclitaxel for patients with previously treated advanced gastric cancer.

Shitara K, Yuki S, Tahahari D, Nakamura M, Kondo C, Tsuda T, Kii T, Tsuji Y, Utsunomiya S, Ichikawa D, Hosokawa A, Ishiguro A, Sakai D, Hironaka S, Oze I, Matsuo K, Muro K.

Br J Cancer. 2014; 110(2): 271-277

Validation study of a prognostic classification in patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy.

Shitara K, Yuki S, Yamazaki K, Naito Y, Fukushima H, Komatsu Y, Yasui H, Takano T, Muro K.

J Cancer Res Clin Oncol. 2013; 139(4): 595-603

Endoscopic in vivo cellular imaging of superficial squamous cell carcinoma of the head and neck by using an integrated endocytoscopy system (with video).

Shimizu Y, Takahashi M, Yoshida T, Ono S, Mabe K, Kato M, Asaka M, Hatanaka K, Sakamoto N.

Gastrointest Endosc. 2013; 78(2): 351-358

Pharmacokinetic assessment of irinotecan, SN-38, and SN-38-glucuronide: a substudy of the FIRIS study.

Satoh T, Yasui H, Muro K, Komatsu Y, Sameshima S, Yamaguchi K, Sugihara K.

Anticancer Res. 2013; 33(9): 3845-3853

Gastric varices secondary to splenic vein occlusion due to pancreatic diseases.

Sato T, Kitagawa S, Kimura M, Ohmura T, Karino Y, Toyota J.

Therapeutic Endoscopy (Pancreatic Disorder and Therapy). 2013; 3: 1-5

Outcomes and predictive factors of "not self-completion" in gastric endoscopic submucosal dissection for novice operators.

Ono S, Kato M, Nakagawa M, Imai A, Yamamoto K, Shimizu Y.

Surg Endosc. 2013; 27(10): 3577-3583

Human intestinal spirochetosis is significantly associated with sessile serrated adenomas/polyps.

Omori S, Mabe K, Hatanaka K, Ono M, Matsumoto M, Takahashi M, Yoshida T, Ono S, Shimizu Y, Sugai N, Suzuki A, Katsuki S, Fujii T, Kato M, Sakamoto N.

Pathol-Res Pract. 2014; 210(7): 440-443

Hypoxia-inducible factors activate CD133 promoter through ETS Family transcription factors.

Ohnishi S, Maehara O, Nakagawa K, Kameya A, Otaki K, Fujita H, Higashi R, Takagi K, Asaka M, Sakamoto N, Kobayashi M, Takeda H.

PLoS One. 2013; 8(6): e66255

Impact of anticancer treatment on recurrent obstruction in covered metallic stents for malignant biliary obstruction.

Nakai Y, Isayama H, Mukai T, Itoi T, Maetani I, Kawakami H, Yasuda I, Maguchi H, Ryozawa S, Hanada K, Hasebe O, Ito K, Kawamoto H, Mochizuki H, Igarashi Y, Irisawa A, Sasaki T, Togawa O, Hara T, Kamada H, Toda N, Hamada T, Kogure H.

J Gastroenterol. 2013; 48(11): 1293-1299

Serotonin 2C receptor antagonism ameliorates noveltyinduced hypophagia in aged mice.

Nahata M, Muto S, Nakagawa K, Ohnishi S, Sadakane C, Saegusa Y, Iizuka S, Hattori T, Asaka M, Takeda H.

Psychoneuroendocrinology. 2013; 38(10): 2051-2064

Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan.

Murakami K, Furuta T, Ando T, Nakajima T, Inui Y, Oshima T, Tomita T, Mabe K, Sasaki M, Suganuma T, Nomura H, Satoh K, Hori S, Inoue S, Tomokane T, Kudo M, Inaba T, Take S, Ohkusa T, Yamamoto S, Mizuno S, Kamoshida T, Amagai K, Iwamoto J, Miwa J, Kodama M, Okimoto T, Kato M, Asaka M; For the Japan GAST Study Group.

J Gastroenterol. 2013; 48(10): 1128-1135

A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury.

Kurokawa S, Katsuki S, Fujita T, Saitoh Y, Ohta H, Nishikawa K, Sato Y, Sato Y, Ohira K, Yamada M, Kato M.

J Gastroenterol. 2014; 49(2): 239-244

Transpapillary dilation of refractory severe biliary stricture or main pancreatic duct by using a wire-guided diathermic dilator (with video).

Kawakami H, Kuwatani M, Kawakubo K, Eto K, Haba S, Kudo T, Abe Y, Kawahata S, Sakamoto N.

Gasrointest Endosc. 2014; 79(2): 338-343

Changes in Endoscopic Findings of Gastritis after Cure of H.pylori Infection: Multicenter Prospective Trial.

Kato M, Terao S, Adachi K, Nakajima S, Ando T, Yoshida N, Uedo N, Murakami K, Ohara S, Ito M, Uemura N, Shimbo T, Watanabe H, Kato T, Ida K, Study Group for Establishing Endoscopic Diagnosis of Chronic Gastritis.

Dig Endosc. 2013; 25(3): 264-273

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir.

Karino Y, Toyota J, Ikeda K, Suzuki F, Chayama K, Kawakami Y, Ishikawa H, Watanabe H, Hernandez D, Yu F, McPhee F, Kumada H.

J Hepatol. 2013; 58(4): 646-654

Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.

Iwakiri R, Tominaga K, Furuta K, Inamori M, Furuta T, Masuyama H, Kanke K, Nagahara A, Haruma K, Kinoshita Y, Higuchi K, Takahashi S, Kusano M, Iwakiri K, Kato M, Hongo M, Hiraishi H, Watanabe S, Miwa H, Naito Y, Fujimoto K, Arakawa T.

Aliment Pharmacol Ther. 2013; 38(7): 729-740

The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis.

Itoi T, Kamisawa T, Igarashi Y, Kawakami H, Yasuda I, Itokawa F, Kishimoto Y, Kuwatani M, Doi S, Hara S, Moriyasu F, Baron TH.

J Gastroenterol. 2013; 48(4): 504-514

Prospective clinical study of endoscopic ultrasound-guided choledochoduodenostomy with direct metallic stent placement using a forward-viewing echoendoscope.

Hara K, Yamao K, Hijioka S, Mizuno N, Imaoka H, Tajika M, Kondo S, Tanaka T, Haba S, Takeshi O, Nagashio Y, Obayashi T, Shinagawa A, Bhatia V, Shimizu Y, Goto H, Niwa Y.

Endoscopy. 2013; 45(5): 392-396

Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience.

Haba S, Yamao K, Bhatia V, Mizuno N, Hara K, Hijioka S, Imaoka H, Niwa Y, Tajika M, Kondo S, Tanaka T, Shimizu Y, Yatabe Y, Hosoda W, Kawakami H, Sakamoto N.

J Gastroenterol. 2013; 48(8): 973-981

Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer.

Eto K, Kawakami H, Kuwatani M, Kudo T, Abe Y, Kawahata S, Takasawa A, Fukuoka M, Matsuno Y, Asaka M, Sakamoto N.

Br J Cancer. 2013; 108(7): 1488-1494

Endoscopic ultrasound-guided celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multicenter trial.

Doi S. Yasuda I, Kawakami H, Hayashi T, Hisai H, Irisawa A, Mukai T, Katanuma A, Kubota K, Ohnishi T, Ryozawa S, Hara K, Itoi T, Hanada K, Yamao K.

Endoscopy. 2013; 45(5): 362-369

Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit.

Bando H, Yoshino T, Shinozaki E, Nishina T, Yamazaki K, Yamaguchi K, Yuki S, Kajiura S, Fujii S, Yamanaka T, Tsuchihara K, Ohtsu A.

BMC Cancer. 2013; 13(1): 405

>